Amedisys Cash on Hand 2010-2024 | AMED

Amedisys cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Amedisys Annual Cash on Hand
(Millions of US $)
2023 $139
2022 $54
2021 $46
2020 $83
2019 $96
2018 $20
2017 $86
2016 $30
2015 $28
2014 $8
2013 $17
2012 $15
2011 $48
2010 $120
2009 $34
Amedisys Quarterly Cash on Hand
(Millions of US $)
2024-09-30 $245
2024-06-30 $157
2024-03-31 $121
2023-12-31 $139
2023-09-30 $94
2023-06-30 $111
2023-03-31 $69
2022-12-31 $54
2022-09-30 $31
2022-06-30 $49
2022-03-31 $71
2021-12-31 $46
2021-09-30 $128
2021-06-30 $93
2021-03-31 $78
2020-12-31 $83
2020-09-30 $115
2020-06-30 $180
2020-03-31 $178
2019-12-31 $96
2019-09-30 $21
2019-06-30 $14
2019-03-31 $11
2018-12-31 $20
2018-09-30 $14
2018-06-30 $26
2018-03-31 $120
2017-12-31 $86
2017-09-30 $66
2017-06-30 $59
2017-03-31 $48
2016-12-31 $30
2016-09-30 $9
2016-06-30 $10
2016-03-31 $8
2015-12-31 $28
2015-09-30 $57
2015-06-30 $33
2015-03-31 $3
2014-12-31 $8
2014-09-30 $6
2014-06-30 $11
2014-03-31 $3
2013-12-31 $17
2013-09-30 $44
2013-06-30 $30
2013-03-31 $7
2012-12-31 $15
2012-09-30 $39
2012-06-30 $37
2012-03-31 $41
2011-12-31 $48
2011-09-30 $29
2011-06-30 $28
2011-03-31 $149
2010-12-31 $120
2010-09-30 $128
2010-06-30 $116
2010-03-31 $82
2009-12-31 $34
2009-09-30 $45
2009-06-30 $1
2009-03-31 $26
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $2.969B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 0.00
Quest Diagnostics (DGX) United States $18.259B 18.51
DaVita (DVA) United States $13.572B 17.55
Encompass Health (EHC) United States $10.188B 24.02
Chemed (CHE) United States $8.593B 26.41
Elanco Animal Health (ELAN) United States $6.605B 15.72
RadNet (RDNT) United States $6.073B 134.49
Option Care Health (OPCH) United States $3.936B 18.65
LifeStance Health (LFST) United States $2.832B 0.00
Astrana Health (ASTH) United States $2.369B 32.39
Addus HomeCare (ADUS) United States $2.254B 26.45
U.S Physical Therapy (USPH) United States $1.477B 38.82
Aveanna Healthcare Holdings (AVAH) United States $1.128B 0.00
Pennant (PNTG) United States $1.070B 43.25
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
Psychemedics (PMD) United States $0.014B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00